loading page

Right ventricular remodeling after transapical transcatheter mitral valve implantation for severe mitral regurgitation.
  • +7
  • Sara Hungerford,
  • Nicole Bart,
  • Paul Jansz,
  • Sharon Kay,
  • Sam Emmanuel,
  • Mayooran Namasivayam,
  • Gry Dahle,
  • Alison Duncan,
  • Christopher S. Hayward,
  • David W. M. Muller
Sara Hungerford
St Vincent's Hospital Sydney
Author Profile
Nicole Bart
St Vincent's Hospital Sydney
Author Profile
Paul Jansz
St Vincent's Hospital Sydney
Author Profile
Sharon Kay
The University of Sydney
Author Profile
Sam Emmanuel
St Vincent's Hospital Sydney
Author Profile
Mayooran Namasivayam
St Vincent's Hospital Sydney
Author Profile
Gry Dahle
Oslo University Hospital
Author Profile
Alison Duncan
Royal Brompton Hospital
Author Profile
Christopher S. Hayward
St Vincent's Hospital Sydney
Author Profile
David W. M. Muller
St Vincent's Hospital Sydney
Author Profile

Abstract

Background: Transapical transcatheter mitral valve implantation (TMVI) may be a therapeutic option for patients with severe mitral regurgitation (MR) excluded from cardiac surgery due to excessive risk. Common reasons for exclusion from surgery are pulmonary hypertension and right ventricular (RV) dysfunction. The effect of TMVI on RV function has not previously been well-characterized. Objectives: The aim of this study was to examine the procedural and 3-month impact of TMVI on RV hemodynamics and remodeling. Methods: This was a multi-center, retrospective, observational cohort study of patients with >3+MR undergoing TMVI. Pre- and post-TMVI hemodynamics were assessed with right heart catheterization. RV remodeling was assessed at baseline, pre-discharge and at 3-months by echocardiography. Results: Forty-six patients (age 72±9 years; 34 men) with ≥3+MR underwent TMVI over a 5-year period. Successful device implantation was achieved in all patients with abolition of MR (p<0.001) and reduction in left-ventricular end-diastolic volume (p=0.001). RV stroke work index increased intra-operatively (7±4g/m/beat/m² vs 11±5g/m/beat/m²; p<0.001). At 3-months there were reductions in severity of tricuspid regurgitation (TR) (p<0.001) and pulmonary artery systolic pressure (PASP) (49±16mmHg vs 36±12mmHg; p<0.001), and improvements in RV fractional area change (28±7% vs 34±9%, p<0.001), tricuspid annular plane systolic excursion (TAPSE) (1.0±0.3 vs 1.5±0.5cm, p=0.03), and RV free wall longitudinal strain (-14.2±5.0 vs -17.6±7.3, p=0.05). Conclusions: Transapical TMVI results in significant improvement of RV function that is sustained to 3 months as evidenced by reductions in TR severity and PASP, and improvements in RV fractional area change, TAPSE, and RV free wall longitudinal strain.